In May, a new subway segment will connect downtown Los Angeles to the Pacific Ocean. What today can be an hours-long drive ...

Scientists at Memorial Sloan Kettering Cancer Center (MSK) and their colleagues are shedding new light on a tumor’s earliest ...

What actually matters in AI right now? It’s getting harder to tell amid the constant launches, hype, and warnings. To cut ...

Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine ...

Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc. ("Takara Bio"), today announced data from a benchmark ...

Researchers are gaining a new appreciation for the genes on the X and Y chromosomes and how they shape sex differences in ...

Homozygous but not heterozygous loss of Pten in sporadic mouse models of SHH-medulloblastoma greatly accelerates tumor formation, not metastasis, through increased survival of differentiated cells and ...

Methodology that is not complete, as well as discrepancies regarding the proposed mode of action of lipoxin A4, are significant weaknesses.

Anthropic's new flagship model Claude Opus 4.7 beat every benchmark we threw at it, and eats tokens like a hungry teenager.

Caris POA members advance precision medicine through collaborative research aimed at improving clinical outcomes for cancer ...